ASML vs ASUR

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

ASUR exhibits a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to assess bankruptcy risk. Despite strong revenue growth of 23.7% and a bullish analyst recommendation (strong_buy), the company is unprofitable with negative profit and operating margins, weak cash conversion, and deteriorating earnings quality. While forward valuation metrics appear reasonable at a Forward P/E of 10.14, the stock trades below its 52-week high and has underperformed peers, offset by improving recent EPS trends and insider sentiment of 60/100. The absence of key financial data (e.g., cash, debt, EV) limits conviction, warranting caution despite growth signals.